Fetal progenitor cell transplantation treats methylmalonic aciduria in a mouse model
Journal Article
·
· Biochemical and Biophysical Research Communications
- Metabolic Research, Murdoch Childrens Research Institute, The University of Melbourne, Department of Paediatrics, Royal Children's Hospital, Flemington Road, Parkville, VIC 3052 (Australia)
- Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville (Australia)
- Gastro and Food Allergy, Murdoch Childrens Research Institute, Parkville (Australia)
Highlights: Black-Right-Pointing-Pointer Fetal cells were transplanted into a methylmalonic acid mouse model. Black-Right-Pointing-Pointer Cell engraftment was detected in liver, spleen and bone marrow. Black-Right-Pointing-Pointer Biochemical disease correction was measured in blood samples. Black-Right-Pointing-Pointer A double dose of 5 million cells (1 week apart) proved more effective. Black-Right-Pointing-Pointer Higher levels of engraftment may be required for greater disease correction. -- Abstract: Methylmalonic aciduria is a rare disorder caused by an inborn error of organic acid metabolism. Current treatment options are limited and generally focus on disease management. We aimed to investigate the use of fetal progenitor cells to treat this disorder using a mouse model with an intermediate form of methylmalonic aciduria. Fetal liver cells were isolated from healthy fetuses at embryonic day 15-17 and intravenously transplanted into sub-lethally irradiated mice. Liver donor cell engraftment was determined by PCR. Disease correction was monitored by urine and blood methylmalonic acid concentration and weight change. Initial studies indicated that pre-transplantation sub-lethal irradiation followed by transplantation with 5 million cells were suitable. We found that a double dose of 5 million cells (1 week apart) provided a more effective treatment. Donor cell liver engraftment of up to 5% was measured. Disease correction, as defined by a decrease in blood methylmalonic acid concentration, was effected in methylmalonic acid mice transplanted with a double dose of cells and who showed donor cell liver engraftment. Mean plasma methylmalonic acid concentration decreased from 810 {+-} 156 (sham transplanted) to 338 {+-} 157 {mu}mol/L (double dose of 5 million cells) while mean blood C3 carnitine concentration decreased from 20.5 {+-} 4 (sham transplanted) to 5.3 {+-} 1.9 {mu}mol/L (double dose of 5 million cells). In conclusion, higher levels of engraftment may be required for greater disease correction; however these studies show promising results for cell transplantation biochemical correction of a metabolic disorder.
- OSTI ID:
- 22210274
- Journal Information:
- Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 1 Vol. 427; ISSN 0006-291X; ISSN BBRCA9
- Country of Publication:
- United States
- Language:
- English
Similar Records
Graft versus host inhibition. IX. Therapeutic potential of combined fetal liver and thymus cells as a universal hematopoietic stem cell source for transplantation. Final report 1 Mar 72--31 Jul 77
Transfusion-associated graft-versus-host disease
Transplantation of hematopoietic and lymphoid cells in mice. [X radiation]
Technical Report
·
Tue Jan 17 23:00:00 EST 1978
·
OSTI ID:7086128
Transfusion-associated graft-versus-host disease
Journal Article
·
Sat Sep 01 00:00:00 EDT 1990
· Yale Journal of Biology and Medicine; (USA)
·
OSTI ID:5839612
Transplantation of hematopoietic and lymphoid cells in mice. [X radiation]
Journal Article
·
Wed Mar 31 23:00:00 EST 1976
· Transplantation; (United States)
·
OSTI ID:7364211